SCWorx Corp. — Cyborg Score 4/10

Strategic Profile

SCWorx develops software modules including virtualized item master file repair, electronic medical record management, charge description master management, contract management, rebate management, and big data analytics. The company sells its solutions through a direct sales force and distribution and reseller partnerships. As a micro-cap OTC company, SCWorx operates in a specialized healthcare IT niche addressing data quality and supply chain optimization challenges.

Cyborg Score Rationale

SCWorx operates in a high-need healthcare data segment but faces significant scale challenges. For the full year ended December 31, 2024, SCWorx reported sales of $2.99 million with a net loss of $1.14 million. The company has minimal analyst coverage and trades on OTC markets with a very small market capitalization (~$1.2M), limiting institutional liquidity and visibility.

Top Insights

• Focused supply chain optimization targeting high-margin healthcare provider market with documented cost-saving benefits
• Early revenue stage ($2.99M in 2024) with operating losses, indicating pre-profitability growth phase
• Proprietary analytics platform (Cubenix™) and item master data governance as core competitive differentiator
• OTC listing with minimal analyst coverage limits institutional capital access and growth trajectory visibility

Named Competitors

• Supply Chain Network — Enterprise resource planning with healthcare supply chain modules
• Oracle Health Supply Chain — Healthcare supply chain and inventory management solutions
• Infor CloudSuite — Cloud-based supply chain and procurement for healthcare

Recent Developments

• (December 2024) Reported full-year 2024 revenue of $2.99 million with net loss of $1.14 million
• (May 2026) Stock trading on OTCPK with market cap approximately $1.184 million

Open the full interactive SCWorx Corp. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.